Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscriptions
Search
Cardiovascular News
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscriptions
Tag: Sanofi
Alirocumab receives EC approval in established atherosclerotic cardiovascular disease
28th March 2019
The European Commission (EC) has approved the use of alirocumab (Praluent, Sanofi), a PCSK9 inhibito...
Edit with Live CSS